Which drug class is generally best tolerated because its target, beta-1,3-glucan, is entirely absent from human cells?
Choose an answer, then check it.
Clinical Pharmacology · Antifungal and Antiparasitic Medications
Antifungal Medications
On this page 6 sections
In 30 seconds
Antifungal drugs are organized by the fungal target they attack: the fungal cell membrane, the enzyme that builds it, or the fungal cell wall. Because fungal cells are far more like human cells than bacteria are, antifungals tend to carry more collateral toxicity, and systemic agents interact heavily with other drugs through shared liver enzyme pathways. Fungal infections become a serious threat mainly when the immune system is compromised, so these drugs show up constantly in oncology, transplant, and critical care settings. Knowing which class hits which target predicts both the drug's spectrum and its signature toxicity.
The college version
Polyenes: Amphotericin B and Nystatin
Amphotericin B binds ergosterol, the cholesterol-equivalent sterol in fungal membranes, and pries open pores that let ions leak out and kill the cell. Because ergosterol resembles human cholesterol, amphotericin B also binds host membranes, producing its two hallmark problems: infusion-related reactions (fever, chills, rigors) and nephrotoxicity with wasting of potassium and magnesium as kidney tubules are damaged. Lipid formulations wrap the drug in a lipid carrier that limits free drug delivery to the kidney, substantially improving tolerability while preserving activity against serious systemic fungi. Nystatin works by the same pore-forming mechanism but is used only topically or orally for candidiasis of the skin, mouth, or esophagus, because it is not absorbed systemically.
Azoles
Azoles block lanosterol 14-alpha-demethylase, a cytochrome P450 enzyme fungi need to convert lanosterol into ergosterol; without ergosterol the membrane cannot form properly. Fluconazole penetrates cerebrospinal fluid exceptionally well and is a mainstay for candidiasis and cryptococcal disease, including maintenance therapy after acute treatment. Itraconazole has negative inotropic effects and can precipitate or worsen heart failure, so it is used cautiously in cardiac dysfunction. Voriconazole is first-line for invasive mold infections but causes visual disturbances (altered color perception, blurring) and phototoxic skin reactions, and its unpredictable metabolism means blood levels are monitored to keep dosing in a therapeutic window. Posaconazole and isavuconazole extend coverage to a broader range of molds and are often chosen for prophylaxis or treatment in severely immunocompromised patients. As a class, azoles cause hepatotoxicity requiring liver monitoring and prolong the QT interval with the notable exception of isavuconazole, which shortens QT instead. Because azoles inhibit human CYP450 enzymes, not just the fungal version, they interact with an enormous number of other medications metabolized through the same pathways.
Echinocandins
Caspofungin, micafungin, and anidulafungin inhibit beta-1,3-glucan synthase, blocking production of a structural polysaccharide in the fungal cell wall. Human cells have no cell wall, so this target is essentially fungus-specific, which explains why echinocandins are remarkably well tolerated. This favorable safety profile plus reliable activity makes them first-line for invasive candidiasis. Their limitation is pharmacokinetic: poor penetration into the central nervous system and urinary tract means they are not useful for fungal meningitis or urinary infections, and they are available only as intravenous formulations.
Other Agents
Flucytosine is incorporated into fungal RNA after conversion inside the fungal cell, disrupting protein synthesis; it is never used alone because resistance develops rapidly, but combined with amphotericin B it is standard for cryptococcal meningitis. Its major adverse effect is bone marrow suppression, requiring blood count monitoring. Terbinafine accumulates in keratin and disrupts ergosterol synthesis at an earlier step than the azoles, making it the drug of choice for dermatophyte onychomycosis given as extended oral courses; hepatotoxicity is the key safety concern requiring liver monitoring before and during therapy. Topical agents such as clotrimazole (an azole) and ciclopirox (a different mechanism disrupting fungal metal-dependent enzymes) treat localized skin, nail, and mucosal infections without systemic exposure or interactions.
Practical Themes
Systemic antifungals interact heavily with other drugs largely because azoles, and to a lesser extent other classes, act on or are metabolized by CYP450 enzymes shared with countless medications, so a new azole prescription warrants a full interaction check. Fungal infections are more common in immunocompromised patients because healthy cell-mediated immunity and intact mucosal or skin barriers normally keep ubiquitous fungi in check; neutropenia, HIV, transplant immunosuppression, and prolonged broad-spectrum antibiotic use all tip the balance toward invasive disease. Monitoring centers on renal function and electrolytes with amphotericin B, liver function with azoles and terbinafine, visual and cardiac status with specific azoles, and blood counts with flucytosine.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of a fungus cell like a little house. Amphotericin B pokes holes in its walls so everything leaks out, but our own cells are built from similar material, so it can poke a few holes in us too, especially in the kidneys. Azoles stop the workers from ever building good walls, but since our bodies use some of the same tools those workers use, azoles jam up our tools too, which is why they clash with so many other medicines. Echinocandins attack a woven-fiber wall that only fungi have, so they barely bother us, making them one of the safest choices. People with weak defenses, like someone fighting cancer treatment or a transplant, have fewer guards watching for fungus houses popping up, so they get sick from fungi far more often than healthy people do.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with cryptococcal meningitis is started on amphotericin B plus flucytosine. What lab parameter should be monitored specifically because of the flucytosine, and why?
Show answer
Complete blood count (white cells, platelets) should be monitored because flucytosine can cause bone marrow suppression.
Flucytosine gets pulled into fungal cells and messes up their protein-making machinery, but it can also affect the bone marrow, where blood cells are made, so counts need watching to catch a drop early.
An echinocandin is being considered for a patient with a suspected fungal urinary tract infection. Explain why this class is a poor choice for that indication.
Show answer
Echinocandins achieve poor penetration into the urinary tract, so they don't reach high enough concentrations there to treat a urinary fungal infection effectively.
Even though echinocandins work well in the bloodstream and organs, they don't collect in urine the way some other antifungals do, so a bladder or kidney infection would keep growing despite treatment.
Quick check
3 questions here. Answers stay hidden until you check.
A patient on voriconazole reports new difficulty distinguishing colors and increased sunburn with minimal sun exposure. Which class-specific issue does this represent?
Choose an answer, then check it.
Why do azole antifungals cause so many drug-drug interactions?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.